QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer

Clinical trial NCT07110064 · RECRUITING

Trial details

NCT number: NCT07110064
Sponsor: Du Juan
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advance Pancreatic Cancer

Start date: 2025-09-03
Primary completion: 2027-08-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.